ImmunoGen, Inc. (IMGN): Price and Financial Metrics

IMGN POWR Grades

• IMGN scores best on the Value dimension, with a Value rank ahead of 62.52% of US stocks.
• IMGN's strongest trending metric is Quality; it's been moving up over the last 177 days.
• IMGN ranks lowest in Momentum; there it ranks in the 5th percentile.

IMGN Stock Summary

• With a price/sales ratio of 10.88, IMMUNOGEN INC has a higher such ratio than 89.3% of stocks in our set.
• In terms of twelve month growth in earnings before interest and taxes, IMMUNOGEN INC is reporting a growth rate of 184.54%; that's higher than 91.57% of US stocks.
• As for revenue growth, note that IMGN's revenue has grown -25.11% over the past 12 months; that beats the revenue growth of just 7.44% of US companies in our set.
• Stocks that are quantitatively similar to IMGN, based on their financial statements, market capitalization, and price volatility, are IMRX, PRQR, VBLT, INO, and OGEN.
• IMGN's SEC filings can be seen here. And to visit IMMUNOGEN INC's official web site, go to www.immunogen.com.

IMGN Valuation Summary

• In comparison to the median Healthcare stock, IMGN's price/sales ratio is 426.83% higher, now standing at 10.8.
• Over the past 243 months, IMGN's price/earnings ratio has gone up 2.7.

Below are key valuation metrics over time for IMGN.

IMGN Growth Metrics

The 4 year cash and equivalents growth rate now stands at 95.39%.
• Its 3 year cash and equivalents growth rate is now at 61.86%.
• Its year over year cash and equivalents growth rate is now at 54.58%.

Over the past 15 months, IMGN's revenue has gone down $41,034,000.

The table below shows IMGN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	95.607	-215.477	-201.093
2022-06-30	89.442	-186.309	-160.677
2022-03-31	92.228	-166.197	-129.397
2021-12-31	69.856	-169.416	-139.303
2021-09-30	127.662	-115.007	-70.743
2021-06-30	136.641	-110.612	-55.778

IMGN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• IMGN has a Quality Grade of C, ranking ahead of 34.67% of graded US stocks.
• IMGN's asset turnover comes in at 0.393 -- ranking 121st of 682 Pharmaceutical Products stocks.
• TARO, HTBX, and ENTA are the stocks whose asset turnover ratios are most correlated with IMGN.

The table below shows IMGN's key quality metrics over time.